Skip to main content
Top
Published in:

01-12-2025 | Respiratory Microbiota

The Neuroimmune Axis in Gastrointestinal Disorders – An Underrecognized Problem

Authors: Laura A. Pace, Niwen Kong, Mohamed I. Itani, James Hemp

Published in: Current Gastroenterology Reports | Issue 1/2025

Login to get access

Abstract

Purpose of Review

We present an introduction to the neuroimmune axis with a focus on the gastrointestinal system, its role in numerous chronic multisystem disorders, and emerging tools and therapies to diagnose and treat these conditions.

Recent Findings

There have recently been tremendous breakthroughs in our understanding of how the nervous, immune, and endocrine systems, as well as the extracellular matrix and microbiota, interact within the gastrointestinal system to modulate health and disease.
Literature
2.
go back to reference McKay DM, et al. Neuroimmunophysiology of the Gastrointestinal tract. Am J Physiol -Gastrointest Liver Physiol. 2024;326:G712–25.PubMedCrossRef McKay DM, et al. Neuroimmunophysiology of the Gastrointestinal tract. Am J Physiol -Gastrointest Liver Physiol. 2024;326:G712–25.PubMedCrossRef
3.
go back to reference Wolterink RGJK, Wu GS, Chiu IM, Veiga-Fernandes H. Neuroimmune interactions in peripheral organs. Annu Rev Neurosci. 2022;45:339–60.PubMedCentralCrossRef Wolterink RGJK, Wu GS, Chiu IM, Veiga-Fernandes H. Neuroimmune interactions in peripheral organs. Annu Rev Neurosci. 2022;45:339–60.PubMedCentralCrossRef
4.
go back to reference Wallrapp A, Chiu IM. Neuroimmune interactions in the intestine. Annu Rev Immunol. 2024;42:489–519.PubMedCrossRef Wallrapp A, Chiu IM. Neuroimmune interactions in the intestine. Annu Rev Immunol. 2024;42:489–519.PubMedCrossRef
6.
go back to reference Verheijden S, Boeckxstaens GE. Neuroimmune interaction and the regulation of intestinal immune homeostasis. Am J Physiol-gastr L. 2018;314:G75–80. Verheijden S, Boeckxstaens GE. Neuroimmune interaction and the regulation of intestinal immune homeostasis. Am J Physiol-gastr L. 2018;314:G75–80.
7.
go back to reference Jacobson A, Yang D, Vella M, Chiu IM. The intestinal neuro-immune axis: crosstalk between neurons, immune cells, and microbes. Mucosal Immunol. 2021;14:555–65.PubMedPubMedCentralCrossRef Jacobson A, Yang D, Vella M, Chiu IM. The intestinal neuro-immune axis: crosstalk between neurons, immune cells, and microbes. Mucosal Immunol. 2021;14:555–65.PubMedPubMedCentralCrossRef
8.
go back to reference Altieri A, Visser GV, Buechler MB. Enter the matrix: Fibroblast-immune cell interactions shape extracellular matrix deposition in health and disease. F1000Research. 2024;13:119.PubMedPubMedCentral Altieri A, Visser GV, Buechler MB. Enter the matrix: Fibroblast-immune cell interactions shape extracellular matrix deposition in health and disease. F1000Research. 2024;13:119.PubMedPubMedCentral
9.
go back to reference Sutherland TE, Dyer DP, Allen JE. The extracellular matrix and the immune system: A mutually dependent relationship. Science. 2023;379:eabp8964.PubMedCrossRef Sutherland TE, Dyer DP, Allen JE. The extracellular matrix and the immune system: A mutually dependent relationship. Science. 2023;379:eabp8964.PubMedCrossRef
11.
go back to reference Godinho-Silva C, Cardoso F, Veiga-Fernandes H. Neuro–Immune cell units: A new paradigm in physiology. Annu Rev Immunol. 2018;37:1–28. Godinho-Silva C, Cardoso F, Veiga-Fernandes H. Neuro–Immune cell units: A new paradigm in physiology. Annu Rev Immunol. 2018;37:1–28.
13.
go back to reference Spencer NJ, Hu H. Enteric nervous system: sensory transduction, neural circuits and Gastrointestinal motility. Nat Rev Gastroentero. 2020;17:338–51.CrossRef Spencer NJ, Hu H. Enteric nervous system: sensory transduction, neural circuits and Gastrointestinal motility. Nat Rev Gastroentero. 2020;17:338–51.CrossRef
14.
go back to reference Bon-Frauches AC, Boesmans W. The enteric nervous system: the hub in a star network. Nat Rev Gastroentero. 2020;17:717–8.CrossRef Bon-Frauches AC, Boesmans W. The enteric nervous system: the hub in a star network. Nat Rev Gastroentero. 2020;17:717–8.CrossRef
15.
go back to reference Furness JB, Jones C, Nurgali K, Clerc N. Intrinsic primary afferent neurons and nerve circuits within the intestine. Prog Neurobiol. 2004;72:143–64.PubMedCrossRef Furness JB, Jones C, Nurgali K, Clerc N. Intrinsic primary afferent neurons and nerve circuits within the intestine. Prog Neurobiol. 2004;72:143–64.PubMedCrossRef
17.
go back to reference Furness JB. Novel gut afferents: intrinsic afferent neurons and intestinofugal neurons. Auton Neurosci. 2006;125:81–5.PubMedCrossRef Furness JB. Novel gut afferents: intrinsic afferent neurons and intestinofugal neurons. Auton Neurosci. 2006;125:81–5.PubMedCrossRef
19.
go back to reference Furness JB. The enteric nervous system and neurogastroenterology. Nat Rev Gastroentero. 2012;9:286–94.CrossRef Furness JB. The enteric nervous system and neurogastroenterology. Nat Rev Gastroentero. 2012;9:286–94.CrossRef
20.
go back to reference Choi EL, Taheri N, Zhang Y, Matsumoto K, Hayashi Y. The critical role of muscularis macrophages in modulating the enteric nervous system function and Gastrointestinal motility. J Smooth Muscle Res. 2024;60:1–9.PubMedPubMedCentralCrossRef Choi EL, Taheri N, Zhang Y, Matsumoto K, Hayashi Y. The critical role of muscularis macrophages in modulating the enteric nervous system function and Gastrointestinal motility. J Smooth Muscle Res. 2024;60:1–9.PubMedPubMedCentralCrossRef
23.
go back to reference Muller PA, et al. Crosstalk between muscularis macrophages and enteric neurons regulates Gastrointestinal motility. Cell. 2014;158:1210.PubMedCrossRef Muller PA, et al. Crosstalk between muscularis macrophages and enteric neurons regulates Gastrointestinal motility. Cell. 2014;158:1210.PubMedCrossRef
25.
go back to reference Graham KD, et al. Robust, 3-Dimensional visualization of human colon enteric nervous system without tissue sectioning. Gastroenterology. 2020;158:2221–e22355.PubMedCrossRef Graham KD, et al. Robust, 3-Dimensional visualization of human colon enteric nervous system without tissue sectioning. Gastroenterology. 2020;158:2221–e22355.PubMedCrossRef
26.
go back to reference Worthington JJ, Reimann F, Gribble FM. Enteroendocrine cells-sensory sentinels of the intestinal environment and orchestrators of mucosal immunity. Mucosal Immunol. 2018;11:3–20.PubMedCrossRef Worthington JJ, Reimann F, Gribble FM. Enteroendocrine cells-sensory sentinels of the intestinal environment and orchestrators of mucosal immunity. Mucosal Immunol. 2018;11:3–20.PubMedCrossRef
27.
go back to reference Sternini C, Anselmi L, Rozengurt E. Enteroendocrine cells: a site of ‘taste’ in Gastrointestinal chemosensing. Curr Opin Endocrinol Diabetes Obes. 2008;15:73–8.PubMedPubMedCentralCrossRef Sternini C, Anselmi L, Rozengurt E. Enteroendocrine cells: a site of ‘taste’ in Gastrointestinal chemosensing. Curr Opin Endocrinol Diabetes Obes. 2008;15:73–8.PubMedPubMedCentralCrossRef
28.
go back to reference Gribble FM, Reimann F. Function and mechanisms of enteroendocrine cells and gut hormones in metabolism. Nat Rev Endocrinol. 2019;15:226–37.PubMedCrossRef Gribble FM, Reimann F. Function and mechanisms of enteroendocrine cells and gut hormones in metabolism. Nat Rev Endocrinol. 2019;15:226–37.PubMedCrossRef
29.
go back to reference Nwako JG, McCauley HA. Enteroendocrine cells regulate intestinal homeostasis and epithelial function. Mol Cell Endocrinol. 2024;593:112339.PubMedCrossRef Nwako JG, McCauley HA. Enteroendocrine cells regulate intestinal homeostasis and epithelial function. Mol Cell Endocrinol. 2024;593:112339.PubMedCrossRef
30.
go back to reference Kaelberer MM, Rupprecht LE, Liu WW, Weng P, Bohórquez DV. Neuropod cells: emerging biology of the Gut-Brain sensory transduction. Annu Rev Neurosci. 2020;43:1–17.CrossRef Kaelberer MM, Rupprecht LE, Liu WW, Weng P, Bohórquez DV. Neuropod cells: emerging biology of the Gut-Brain sensory transduction. Annu Rev Neurosci. 2020;43:1–17.CrossRef
33.
go back to reference Powell N, Walker MM, Talley NJ. The mucosal immune system: master regulator of bidirectional gut–brain communications. Nat Rev Gastroentero. 2017;14:143–59.CrossRef Powell N, Walker MM, Talley NJ. The mucosal immune system: master regulator of bidirectional gut–brain communications. Nat Rev Gastroentero. 2017;14:143–59.CrossRef
36.
go back to reference Furuzawa-Carballeda J, et al. New insights into the pathophysiology of achalasia and implications for future treatment. World J Gastroentero. 2016;22:7892–907.CrossRef Furuzawa-Carballeda J, et al. New insights into the pathophysiology of achalasia and implications for future treatment. World J Gastroentero. 2016;22:7892–907.CrossRef
37.
go back to reference Lindberg G, et al. Full-thickness biopsy findings in chronic intestinal pseudo-obstruction and enteric dysmotility. Gut. 2009;58:1084.PubMedCrossRef Lindberg G, et al. Full-thickness biopsy findings in chronic intestinal pseudo-obstruction and enteric dysmotility. Gut. 2009;58:1084.PubMedCrossRef
38.
go back to reference Malagelada C, et al. Comparison between small bowel manometric patterns and full-thickness biopsy histopathology in severe intestinal dysmotility. Neurogastroenterol Motil. 2018;30:e13219.CrossRef Malagelada C, et al. Comparison between small bowel manometric patterns and full-thickness biopsy histopathology in severe intestinal dysmotility. Neurogastroenterol Motil. 2018;30:e13219.CrossRef
39.
go back to reference Galli SJ, Gaudenzio N, Tsai M. Mast cells in inflammation and disease: recent progress and ongoing concerns. Annu Rev Immunol. 2020;38:49–77.PubMedCrossRef Galli SJ, Gaudenzio N, Tsai M. Mast cells in inflammation and disease: recent progress and ongoing concerns. Annu Rev Immunol. 2020;38:49–77.PubMedCrossRef
40.
go back to reference Plum T, Feyerabend TB, Rodewald H-R. Beyond classical immunity: mast cells as signal converters between tissues and neurons. Immunity. 2024;57:2723–36.PubMedCrossRef Plum T, Feyerabend TB, Rodewald H-R. Beyond classical immunity: mast cells as signal converters between tissues and neurons. Immunity. 2024;57:2723–36.PubMedCrossRef
42.
go back to reference Xu H, et al. Neurotransmitter and neuropeptide regulation of mast cell function: a systematic review. J Neuroinflamm. 2020;17:356.CrossRef Xu H, et al. Neurotransmitter and neuropeptide regulation of mast cell function: a systematic review. J Neuroinflamm. 2020;17:356.CrossRef
43.
go back to reference de Haas AH, van Weering HRJ, de Jong EK, Boddeke HWGM, Biber KPH. Neuronal chemokines: versatile messengers in central nervous system cell interaction. Mol Neurobiol. 2007;36:137–51.PubMedPubMedCentralCrossRef de Haas AH, van Weering HRJ, de Jong EK, Boddeke HWGM, Biber KPH. Neuronal chemokines: versatile messengers in central nervous system cell interaction. Mol Neurobiol. 2007;36:137–51.PubMedPubMedCentralCrossRef
44.
go back to reference Stakenborg N, Viola MF, Boeckxstaens GE. Intestinal neuro-immune interactions: focus on macrophages, mast cells and innate lymphoid cells. Curr Opin Neurobiol. 2020;62:68–75.PubMedPubMedCentralCrossRef Stakenborg N, Viola MF, Boeckxstaens GE. Intestinal neuro-immune interactions: focus on macrophages, mast cells and innate lymphoid cells. Curr Opin Neurobiol. 2020;62:68–75.PubMedPubMedCentralCrossRef
45.
go back to reference Nelson M, et al. Lower esophageal sphincter muscle of patients with achalasia exhibits profound mast cell degranulation. Neurogastroenterol Motil. 2021;33:e14055.PubMedCrossRef Nelson M, et al. Lower esophageal sphincter muscle of patients with achalasia exhibits profound mast cell degranulation. Neurogastroenterol Motil. 2021;33:e14055.PubMedCrossRef
46.
go back to reference Barbara G, et al. Mast Cell-Dependent excitation of Visceral-Nociceptive sensory neurons in irritable bowel syndrome. Gastroenterology. 2007;132:26–37.PubMedCrossRef Barbara G, et al. Mast Cell-Dependent excitation of Visceral-Nociceptive sensory neurons in irritable bowel syndrome. Gastroenterology. 2007;132:26–37.PubMedCrossRef
49.
go back to reference Bereshchenko O, Bruscoli S, Riccardi C, Glucocorticoids. Sex hormones, and immunity. Front Immunol. 2018;9:1332. Bereshchenko O, Bruscoli S, Riccardi C, Glucocorticoids. Sex hormones, and immunity. Front Immunol. 2018;9:1332.
51.
52.
go back to reference Asano Y, et al. Critical role of gut microbiota in the production of biologically active, free catecholamines in the gut lumen of mice. Am J Physiol-gastr L. 2012;303:G1288–95. Asano Y, et al. Critical role of gut microbiota in the production of biologically active, free catecholamines in the gut lumen of mice. Am J Physiol-gastr L. 2012;303:G1288–95.
54.
go back to reference O’Donnell MP, Fox BW, Chao P-H, Schroeder FC, Sengupta P. A neurotransmitter produced by gut bacteria modulates host sensory behaviour. Nature. 2020;583:415–20.PubMedPubMedCentralCrossRef O’Donnell MP, Fox BW, Chao P-H, Schroeder FC, Sengupta P. A neurotransmitter produced by gut bacteria modulates host sensory behaviour. Nature. 2020;583:415–20.PubMedPubMedCentralCrossRef
55.
go back to reference Neuman H, Debelius JW, Knight R, Koren O. Microbial endocrinology: the interplay between the microbiota and the endocrine system. Fems Microbiol Rev. 2015;39:509–21.PubMedCrossRef Neuman H, Debelius JW, Knight R, Koren O. Microbial endocrinology: the interplay between the microbiota and the endocrine system. Fems Microbiol Rev. 2015;39:509–21.PubMedCrossRef
56.
go back to reference Cotton S, Clayton CA, Tropini C. Microbial endocrinology: the mechanisms by which the microbiota influences host sex steroids. Trends Microbiol. 2023;31:1131–42.PubMedCrossRef Cotton S, Clayton CA, Tropini C. Microbial endocrinology: the mechanisms by which the microbiota influences host sex steroids. Trends Microbiol. 2023;31:1131–42.PubMedCrossRef
58.
go back to reference Pally D, Naba A. Extracellular matrix dynamics: A key regulator of cell migration across length-scales and systems. Curr Opin Cell Biol. 2024;86:102309.PubMedPubMedCentralCrossRef Pally D, Naba A. Extracellular matrix dynamics: A key regulator of cell migration across length-scales and systems. Curr Opin Cell Biol. 2024;86:102309.PubMedPubMedCentralCrossRef
59.
go back to reference Ritelli M, et al. Bridging the diagnostic gap for hypermobile Ehlers-Danlos syndrome and hypermobility spectrum disorders: evidence of a common extracellular matrix fragmentation pattern in patient plasma as a potential biomarker. Am J Méd Genet Part A. 2024;e63857. https://doi.org/10.1002/ajmg.a.63857. Ritelli M, et al. Bridging the diagnostic gap for hypermobile Ehlers-Danlos syndrome and hypermobility spectrum disorders: evidence of a common extracellular matrix fragmentation pattern in patient plasma as a potential biomarker. Am J Méd Genet Part A. 2024;e63857. https://​doi.​org/​10.​1002/​ajmg.​a.​63857.
60.
go back to reference Ritelli M, et al. RNA-Seq of dermal fibroblasts from patients with hypermobile Ehlers–Danlos syndrome and hypermobility spectrum disorders supports their categorization as a single entity with involvement of extracellular matrix degrading and Proinflammatory pathomechanisms. Cells. 2022;11:4040.PubMedPubMedCentralCrossRef Ritelli M, et al. RNA-Seq of dermal fibroblasts from patients with hypermobile Ehlers–Danlos syndrome and hypermobility spectrum disorders supports their categorization as a single entity with involvement of extracellular matrix degrading and Proinflammatory pathomechanisms. Cells. 2022;11:4040.PubMedPubMedCentralCrossRef
61.
go back to reference Miller FW. The increasing prevalence of autoimmunity and autoimmune diseases: an urgent call to action for improved understanding, diagnosis, treatment, and prevention. Curr Opin Immunol. 2023;80:102266.PubMedCrossRef Miller FW. The increasing prevalence of autoimmunity and autoimmune diseases: an urgent call to action for improved understanding, diagnosis, treatment, and prevention. Curr Opin Immunol. 2023;80:102266.PubMedCrossRef
62.
go back to reference Conrad N, et al. Incidence, prevalence, and co-occurrence of autoimmune disorders over time and by age, sex, and socioeconomic status: a population-based cohort study of 22 million individuals in the UK. Lancet. 2023;401:1878–90.PubMedCrossRef Conrad N, et al. Incidence, prevalence, and co-occurrence of autoimmune disorders over time and by age, sex, and socioeconomic status: a population-based cohort study of 22 million individuals in the UK. Lancet. 2023;401:1878–90.PubMedCrossRef
63.
go back to reference Sperber AD, et al. Worldwide prevalence and burden of functional Gastrointestinal disorders, results of Rome foundation global study. Gastroenterology. 2021;160:99–e1143.PubMedCrossRef Sperber AD, et al. Worldwide prevalence and burden of functional Gastrointestinal disorders, results of Rome foundation global study. Gastroenterology. 2021;160:99–e1143.PubMedCrossRef
64.
go back to reference Lin C-C, ‘Jerry,’ Tian Y, Tanzi RE, Jorfi M. Approaches for studying neuroimmune interactions in Alzheimer’s disease. Trends Immunol. 2024;45:971–86.PubMedCrossRef Lin C-C, ‘Jerry,’ Tian Y, Tanzi RE, Jorfi M. Approaches for studying neuroimmune interactions in Alzheimer’s disease. Trends Immunol. 2024;45:971–86.PubMedCrossRef
65.
go back to reference He Y, Lu W, Zhou X, Mu J, Shen W. Unraveling Alzheimer’s disease: insights from single-cell sequencing and Spatial transcriptomic. Front Neurol. 2024;15:1515981.PubMedPubMedCentralCrossRef He Y, Lu W, Zhou X, Mu J, Shen W. Unraveling Alzheimer’s disease: insights from single-cell sequencing and Spatial transcriptomic. Front Neurol. 2024;15:1515981.PubMedPubMedCentralCrossRef
66.
69.
go back to reference Martinez-Sanchez N, et al. The sympathetic nervous system in the 21st century: neuroimmune interactions in metabolic homeostasis and obesity. Neuron. 2022;110:3597–626.PubMedPubMedCentralCrossRef Martinez-Sanchez N, et al. The sympathetic nervous system in the 21st century: neuroimmune interactions in metabolic homeostasis and obesity. Neuron. 2022;110:3597–626.PubMedPubMedCentralCrossRef
70.
go back to reference Andreone L. Neuroimmune axis: linking environmental factors to pancreatic β-cell dysfunction in diabetes. Brain Behav Immun - Heal. 2025;43:100926.CrossRef Andreone L. Neuroimmune axis: linking environmental factors to pancreatic β-cell dysfunction in diabetes. Brain Behav Immun - Heal. 2025;43:100926.CrossRef
72.
73.
go back to reference Carnevale D. Neuroimmune axis of cardiovascular control: mechanisms and therapeutic implications. Nat Rev Cardiol. 2022;19:379–94.PubMedCrossRef Carnevale D. Neuroimmune axis of cardiovascular control: mechanisms and therapeutic implications. Nat Rev Cardiol. 2022;19:379–94.PubMedCrossRef
75.
go back to reference Thomasi B, Valdetaro L, Gulbransen B, Tavares-Gomes AL. Neuroimmune connectomes in the gut and their implications in Parkinson’s disease. Mol Neurobiol. 2024;61:2081–98.PubMedCrossRef Thomasi B, Valdetaro L, Gulbransen B, Tavares-Gomes AL. Neuroimmune connectomes in the gut and their implications in Parkinson’s disease. Mol Neurobiol. 2024;61:2081–98.PubMedCrossRef
76.
go back to reference Vacharasin JM, et al. Neuroimmune mechanisms in autism etiology - untangling a complex problem using human cellular models. Oxf Open Neurosci. 2024;3:kvae003.PubMedPubMedCentralCrossRef Vacharasin JM, et al. Neuroimmune mechanisms in autism etiology - untangling a complex problem using human cellular models. Oxf Open Neurosci. 2024;3:kvae003.PubMedPubMedCentralCrossRef
78.
go back to reference Murdock DR, Rosenfeld JA, Lee B. What has the undiagnosed diseases network taught Us about the clinical applications of genomic testing?? Annu Rev Med. 2022;73:575–85.PubMedPubMedCentralCrossRef Murdock DR, Rosenfeld JA, Lee B. What has the undiagnosed diseases network taught Us about the clinical applications of genomic testing?? Annu Rev Med. 2022;73:575–85.PubMedPubMedCentralCrossRef
79.
go back to reference Gray PE, David C. Inborn errors of immunity and autoimmune disease. J Allergy Clin Immunol: Pr. 2023;11:1602–22. Gray PE, David C. Inborn errors of immunity and autoimmune disease. J Allergy Clin Immunol: Pr. 2023;11:1602–22.
80.
go back to reference Notarangelo LD, Bacchetta R, Casanova J-L, Su HC. Human inborn errors of immunity: an expanding universe. Sci Immunol 5, (2020). Notarangelo LD, Bacchetta R, Casanova J-L, Su HC. Human inborn errors of immunity: an expanding universe. Sci Immunol 5, (2020).
81.
go back to reference Akalu YT, Bogunovic D. Inborn errors of immunity: an expanding universe of disease and genetic architecture. Nat Rev Genet. 2024;25:184–95.PubMedCrossRef Akalu YT, Bogunovic D. Inborn errors of immunity: an expanding universe of disease and genetic architecture. Nat Rev Genet. 2024;25:184–95.PubMedCrossRef
82.
go back to reference Redhead C, Taye N, Hubmacher D. En route towards a personalized medicine approach: innovative therapeutic modalities for connective tissue disorders. Matrix Biol. 2023;122:46–54.PubMedPubMedCentralCrossRef Redhead C, Taye N, Hubmacher D. En route towards a personalized medicine approach: innovative therapeutic modalities for connective tissue disorders. Matrix Biol. 2023;122:46–54.PubMedPubMedCentralCrossRef
83.
go back to reference Tangye SG, et al. Human inborn errors of immunity: 2022 update on the classification from the international union of immunological societies expert committee. J Clin Immunol. 2022;42:1473–507.PubMedPubMedCentralCrossRef Tangye SG, et al. Human inborn errors of immunity: 2022 update on the classification from the international union of immunological societies expert committee. J Clin Immunol. 2022;42:1473–507.PubMedPubMedCentralCrossRef
84.
go back to reference Bousfiha A, et al. The 2022 update of IUIS phenotypical classification for human inborn errors of immunity. J Clin Immunol. 2022;42:1508–20.PubMedCrossRef Bousfiha A, et al. The 2022 update of IUIS phenotypical classification for human inborn errors of immunity. J Clin Immunol. 2022;42:1508–20.PubMedCrossRef
85.
87.
go back to reference Chan AY, Torgerson TR. Primary immune regulatory disorders: a growing universe of immune dysregulation. Curr Opin Allergy Clin Immunol. 2020;20:582–90.PubMedPubMedCentralCrossRef Chan AY, Torgerson TR. Primary immune regulatory disorders: a growing universe of immune dysregulation. Curr Opin Allergy Clin Immunol. 2020;20:582–90.PubMedPubMedCentralCrossRef
88.
go back to reference Delmonte OM, Castagnoli R, Calzoni E, Notarangelo LD. Inborn errors of immunity with immune dysregulation: from bench to bedside. Front Pediatr. 2019;7:353.PubMedPubMedCentralCrossRef Delmonte OM, Castagnoli R, Calzoni E, Notarangelo LD. Inborn errors of immunity with immune dysregulation: from bench to bedside. Front Pediatr. 2019;7:353.PubMedPubMedCentralCrossRef
89.
go back to reference Karamanakos A, et al. The expanding clinical spectrum of autoinflammatory diseases with NOD2 variants: a case series and literature review. Front Immunol. 2024;15:1342668.PubMedPubMedCentralCrossRef Karamanakos A, et al. The expanding clinical spectrum of autoinflammatory diseases with NOD2 variants: a case series and literature review. Front Immunol. 2024;15:1342668.PubMedPubMedCentralCrossRef
90.
go back to reference Ogura Y, et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn’s disease. Nature. 2001;411:603–6.PubMedCrossRef Ogura Y, et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn’s disease. Nature. 2001;411:603–6.PubMedCrossRef
91.
go back to reference Williamson KA, et al. Clinical phenotype, NOD2 genotypes, and treatment observations in Yao syndrome: a retrospective case series. Front Immunol. 2024;15:1304792.PubMedPubMedCentralCrossRef Williamson KA, et al. Clinical phenotype, NOD2 genotypes, and treatment observations in Yao syndrome: a retrospective case series. Front Immunol. 2024;15:1304792.PubMedPubMedCentralCrossRef
92.
go back to reference Chan AY, et al. Hematopoietic cell transplantation in patients with primary immune regulatory disorders (PIRD): A primary immune deficiency treatment consortium (PIDTC) survey. Front Immunol. 2020;11:239.PubMedPubMedCentralCrossRef Chan AY, et al. Hematopoietic cell transplantation in patients with primary immune regulatory disorders (PIRD): A primary immune deficiency treatment consortium (PIDTC) survey. Front Immunol. 2020;11:239.PubMedPubMedCentralCrossRef
93.
go back to reference Lamandé SR, Bateman JF. Genetic disorders of the extracellular matrix. Anat Rec. 2020;303:1527–42.CrossRef Lamandé SR, Bateman JF. Genetic disorders of the extracellular matrix. Anat Rec. 2020;303:1527–42.CrossRef
94.
go back to reference Chakravarti S, Enzo E, de Barros MRM, Maffezzoni MBR, Pellegrini G. Genetic disorders of the extracellular matrix: from cell and gene therapy to future applications in regenerative medicine. Annu Rev Genom Hum Genet. 2022;23:193–222.CrossRef Chakravarti S, Enzo E, de Barros MRM, Maffezzoni MBR, Pellegrini G. Genetic disorders of the extracellular matrix: from cell and gene therapy to future applications in regenerative medicine. Annu Rev Genom Hum Genet. 2022;23:193–222.CrossRef
96.
go back to reference Zoppi N, Chiarelli N, Binetti S, Ritelli M, Colombi M. Dermal fibroblast-to-myofibroblast transition sustained by Αvß3 integrin-ILK-Snail1/Slug signaling is a common feature for hypermobile Ehlers-Danlos syndrome and hypermobility spectrum disorders. Biochim Et Biophys Acta Bba - Mol Basis Dis. 2018;1864:1010–23.CrossRef Zoppi N, Chiarelli N, Binetti S, Ritelli M, Colombi M. Dermal fibroblast-to-myofibroblast transition sustained by Αvß3 integrin-ILK-Snail1/Slug signaling is a common feature for hypermobile Ehlers-Danlos syndrome and hypermobility spectrum disorders. Biochim Et Biophys Acta Bba - Mol Basis Dis. 2018;1864:1010–23.CrossRef
97.
101.
go back to reference Chen J, Larsson L, Swarbrick A, Lundeberg J. Spatial landscapes of cancers: insights and opportunities. Nat Rev Clin Oncol. 2024;21:660–74.PubMedCrossRef Chen J, Larsson L, Swarbrick A, Lundeberg J. Spatial landscapes of cancers: insights and opportunities. Nat Rev Clin Oncol. 2024;21:660–74.PubMedCrossRef
103.
go back to reference To A, Yu Z, Sugimura R. Recent advancement in the Spatial immuno-oncology. Semin Cell Dev Biol. 2025;166:22–8.PubMedCrossRef To A, Yu Z, Sugimura R. Recent advancement in the Spatial immuno-oncology. Semin Cell Dev Biol. 2025;166:22–8.PubMedCrossRef
104.
go back to reference Monette A, et al. The society for immunotherapy of cancer perspective on Tissue-Based technologies for Immuno-Oncology biomarker discovery and application. Clin. Cancer Res. 2024;31:439–56. Monette A, et al. The society for immunotherapy of cancer perspective on Tissue-Based technologies for Immuno-Oncology biomarker discovery and application. Clin. Cancer Res. 2024;31:439–56.
105.
go back to reference Kong L, et al. The landscape of immune dysregulation in Crohn’s disease revealed through single-cell transcriptomic profiling in the ileum and colon. Immunity. 2023;56:444–e4585.PubMedPubMedCentralCrossRef Kong L, et al. The landscape of immune dysregulation in Crohn’s disease revealed through single-cell transcriptomic profiling in the ileum and colon. Immunity. 2023;56:444–e4585.PubMedPubMedCentralCrossRef
106.
go back to reference Baker DJ, June CH. Off-the-shelf CAR-T cells could prove paradigm shifting for autoimmune diseases. Cell. 2024;187:4826–8.PubMedCrossRef Baker DJ, June CH. Off-the-shelf CAR-T cells could prove paradigm shifting for autoimmune diseases. Cell. 2024;187:4826–8.PubMedCrossRef
107.
go back to reference Wang X, et al. Allogeneic CD19-targeted CAR-T therapy in patients with severe myositis and systemic sclerosis. Cell. 2024;187:4890–e49049.PubMedCrossRef Wang X, et al. Allogeneic CD19-targeted CAR-T therapy in patients with severe myositis and systemic sclerosis. Cell. 2024;187:4890–e49049.PubMedCrossRef
109.
go back to reference Breckels LM, et al. Advances in Spatial proteomics: mapping proteome architecture from protein complexes to subcellular localizations. Cell Chem Biol. 2024;31:1665–87.PubMedCrossRef Breckels LM, et al. Advances in Spatial proteomics: mapping proteome architecture from protein complexes to subcellular localizations. Cell Chem Biol. 2024;31:1665–87.PubMedCrossRef
110.
go back to reference Method of the Year 2024. Spatial proteomics. Nat Methods. 2024;21:2195–6.CrossRef Method of the Year 2024. Spatial proteomics. Nat Methods. 2024;21:2195–6.CrossRef
114.
115.
117.
go back to reference Merritt CR, et al. Multiplex digital Spatial profiling of proteins and RNA in fixed tissue. Nat Biotechnol. 2020;38:586–99.PubMedCrossRef Merritt CR, et al. Multiplex digital Spatial profiling of proteins and RNA in fixed tissue. Nat Biotechnol. 2020;38:586–99.PubMedCrossRef
Metadata
Title
The Neuroimmune Axis in Gastrointestinal Disorders – An Underrecognized Problem
Authors
Laura A. Pace
Niwen Kong
Mohamed I. Itani
James Hemp
Publication date
01-12-2025
Publisher
Springer US
Published in
Current Gastroenterology Reports / Issue 1/2025
Print ISSN: 1522-8037
Electronic ISSN: 1534-312X
DOI
https://doi.org/10.1007/s11894-025-00973-9

Keynote series | Spotlight on managing health in obesity

Obesity is a major contributor to cardiorenal metabolic disease, but its impact extends throughout the body. Understand how obesity can affect other organ systems and impact treatment, and whether weight-loss measures improve outcomes.

Prof. Eva L. Feldman
Prof. Jonette Keri
Developed by: Springer Medicine
Watch now
Video

Women’s health knowledge hub

Elevate your patient care with our comprehensive, evidence-based medical education on women's health. Designed to help you provide exceptional care for your female patients at every stage of life, we provide expert insights into topics such as reproductive health, menopause, breast cancer and sex-specific health risks and precision medicine.

Read more

Keynote webinar | Spotlight on advances in lupus

  • Live
  • Webinar | 27-05-2025 | 18:00 (CEST)

Systemic lupus erythematosus is a severe autoimmune disease that can cause damage to almost every system of the body. Join this session to learn more about novel biomarkers for diagnosis and monitoring and familiarise yourself with current and emerging targeted therapies.

Join us live: Tuesday 27th May, 18:00-19:15 (CEST)

Prof. Edward Vital
Prof. Ronald F. van Vollenhoven
Developed by: Springer Medicine
Register now
Webinar